[PDF][PDF] Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 …
N Angkasekwinai, J Prawjaeng… - Asian Pacific Journal …, 2022 - researchgate.net
Background: The data on the immunogenicity and efficacy of heterologous primary series
COVID-19 vaccination are still limited. Objective: To investigate the immunogenicity and …
COVID-19 vaccination are still limited. Objective: To investigate the immunogenicity and …
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection
MT Vietri, G D'Elia, G Caliendo, L Passariello… - Vaccine, 2022 - Elsevier
In the present study, immunogenicity data in 61 vaccinated healthcare workers (HCWs)
either infection naïve (naïve HCWs) or with infection of Delta and/or Omicron COVID-19 …
either infection naïve (naïve HCWs) or with infection of Delta and/or Omicron COVID-19 …
[HTML][HTML] Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 …
RH Al-Rifai, F Alhosani, R Abuyadek, S Atef… - Frontiers in …, 2023 - frontiersin.org
Introduction The induction and speed of production of severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) immune biomarkers may vary by type and number of …
coronavirus-2 (SARS-CoV-2) immune biomarkers may vary by type and number of …
Matched versus mixed COVID-19 vaccinations in korean solid organ transplant recipients: an Observational Study
Background. Solid organ transplant recipients (SOTRs) are vulnerable to severe coronavirus
disease 2019 (COVID-19) and exhibit poor antibody responses to COVID-19 vaccines …
disease 2019 (COVID-19) and exhibit poor antibody responses to COVID-19 vaccines …
[HTML][HTML] Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 …
S Hongjaisee, K Chawansuntati, P Sripan… - Vaccine: X, 2023 - Elsevier
Abstract Background In Thailand, early vaccination initiatives for SARS-CoV-2 relied on
CoronaVac (Sinovac Life Sciences) and ChAdOx1 (Oxford–AstraZeneca) vaccines …
CoronaVac (Sinovac Life Sciences) and ChAdOx1 (Oxford–AstraZeneca) vaccines …
Safety of heterologous ChAdOx1-S/BNT162b2 primary schedule versus homologous BNT162b2 vaccination: Insights from an Italian post-marketing study, 2021
F Fortunato, R Prato, G Iannelli… - Human Vaccines & …, 2023 - Taylor & Francis
During COVID-19 vaccination campaign, possible ChAdOx1-S-associated risks of
thrombosis with thrombocytopenia syndrome led to implement ChAdOx1-S/BNT162b2 …
thrombosis with thrombocytopenia syndrome led to implement ChAdOx1-S/BNT162b2 …
[HTML][HTML] Reactogenicity and Humoral Immune Response after Heterologous Vaxzevria/Comirnaty Vaccination in a Group of Individuals Vaccinated in the AOU …
R Venuto, I Giunta, M Vaccaro, V La Fauci, C Ceccio… - Vaccines, 2022 - mdpi.com
On 11 June 2021, the Italian Ministry of Health authorized the heterologous vaccination
schedule. The goals of our retrospective study were to (a) evaluate the undesirable effects …
schedule. The goals of our retrospective study were to (a) evaluate the undesirable effects …
[HTML][HTML] Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population
E Sereejav, A Sandagdorj, P Bazarjav, S Ganbold… - IJID regions, 2023 - Elsevier
Background A nationwide vaccination program against coronavirus disease 2019 (COVID-
19) was started in Mongolia 4 months after the first local transmission, which occurred in …
19) was started in Mongolia 4 months after the first local transmission, which occurred in …
Comparison of immune response parameters between homologous and heterologous COVID-19 vaccines: A scoping review
SSM Khoo, KW Tan, A Mahendran… - Microbes & …, 2024 - accscience.com
It has been over 4 years since the emergence of the coronavirus disease 2019 (COVID-19)
pandemic. This highly contagious respiratory infection has endangered the health of millions …
pandemic. This highly contagious respiratory infection has endangered the health of millions …
Immune Response Against COVID-19 in a Population Aged 18 Years and Above, in 2022, Cali, Colombia
M Galvis Pedraza, A Murica-Viveros… - Cali, Colombia (May …, 2023 - papers.ssrn.com
Abstract Background and Objective: Immunization is a protective measure against COVID‐
19. This research aimed to estimate the association of protective levels of total IgG anti-S …
19. This research aimed to estimate the association of protective levels of total IgG anti-S …